Spac I completes another step of reverse merger with CoGyn Pharmaceuticals
Wednesday, November 04, 2015
Spac I SA completes another step of reverse merger with CoGyn Pharmaceuticals, Inc; transaction to be closed in few weeks.
Extraordinary shareholder meeting held on Nov. 2 approved name change to CoGyn Pharmaceuticals SA and chose new supervisory board.
New supervisory board plans to appoint Robert Cohen as new chairman of management board.
Plans to obtain 10 million zlotys funds in next 3 months to finance development, commercialization and licencing of CoGyn products.
To establish new units in Malta and Hong Kong.
To enter into Chinese market via its joint venture with Kangqi Pharmaceutical Co's unit.
To apply to EU for subsidy for financing of its CoGyn products' clinical trials.
reuters.com
